Fibre Extrusion Technology Ltd (FET) of Leeds, UK reported another successful exhibition at COMPAMED 2025 in Düsseldorf, following closely on the heels of ITMA ASIA in Singapore. This was the second time that FET had exhibited at this leading international trade fair for the medical technology supplier sector, a reflection of the company’s growing role in this sector. More than half of FET’s turnover is currently derived from the burgeoning medical market.
COMPAMED is aimed at suppliers of a wide range of high-quality medical technology components, services and production equipment for the medical industry. FET’s expanding role in the medical sector is therefore an ideal fit for this trade show.
At the exhibition, FET launched its latest ground breaking technology with the FET-500 – Gel Spinning systems for Ultra High Molecular weight polymers such as UHMWPE, boasting significant savings in cost, footprint and environmental factors. With vast flexibility whilst maintaining critical consistency, the FET-500 provides the ability to prove concepts and secure medical device IP. Key benefits include removing the harsh processing chemicals that historically have been used with gel spinning technology. FET’s patent-pending process technology has enabled the process to be compact and environmentally friendly compared to industrial alternatives.
In 2026, FET will be exhibiting at two major trade shows to continue its global drive. This begins with Techtextil, Frankfurt in April, followed by COMPAMED 2026, Dusseldorf in November.
